Six-Year Disease Trajectory in Multiple Sclerosis: A Pre- and Post-Ocrelizumab Treatment Analysis

Samadzade, UlviAlizada, SaidCaliskan, CanMammadov, OrkhanKara, IremOzakbas, Serkan2025-12-302025-12-3020251352-45851477-0970https://hdl.handle.net/20.500.14365/8508eninfo:eu-repo/semantics/closedAccessSix-Year Disease Trajectory in Multiple Sclerosis: A Pre- and Post-Ocrelizumab Treatment AnalysisConference Object